Cargando…
Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409094/ https://www.ncbi.nlm.nih.gov/pubmed/34485659 http://dx.doi.org/10.1016/j.jemep.2021.100710 |
| _version_ | 1783746929970118656 |
|---|---|
| author | Okereke, M. Essar, M.Y. |
| author_facet | Okereke, M. Essar, M.Y. |
| author_sort | Okereke, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8409094 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84090942021-09-01 Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma Okereke, M. Essar, M.Y. Ethics Med Public Health Letter to the Editor Elsevier Masson SAS. 2021-12 2021-08-23 /pmc/articles/PMC8409094/ /pubmed/34485659 http://dx.doi.org/10.1016/j.jemep.2021.100710 Text en © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Okereke, M. Essar, M.Y. Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma |
| title | Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma |
| title_full | Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma |
| title_fullStr | Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma |
| title_full_unstemmed | Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma |
| title_short | Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma |
| title_sort | time to boost covid-19 vaccine manufacturing: the need for intellectual property waiver by big pharma |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409094/ https://www.ncbi.nlm.nih.gov/pubmed/34485659 http://dx.doi.org/10.1016/j.jemep.2021.100710 |
| work_keys_str_mv | AT okerekem timetoboostcovid19vaccinemanufacturingtheneedforintellectualpropertywaiverbybigpharma AT essarmy timetoboostcovid19vaccinemanufacturingtheneedforintellectualpropertywaiverbybigpharma |